Advisor Group Holdings, Inc. Forma Therapeutics Holdings, Inc. Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	BUY	$8.34 - $14.69 $21,000 - $36,989	2,518 New	2,518 $33,000
Q3 2021 Nov 05, 2021	SELL	$21.22 - $25.7 $20,477 - $24,800	-965 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$22.86 - $30.95 $6,858 - $9,285	300 Added 45.11%	965 $24,000
Q3 2020 Nov 12, 2020	BUY	$32.95 - $50.25 $21,911 - $33,416	665 New	665 $33,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.